EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor

Isabella Sutherland, Ming-Fen Ho, Paul E Croarkin iD

Journal of Child and Adolescent Psychopharmacology · 2025

DOI: 10.1089/cap.2024.0082 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, 2025. Verfasst von Isabella Sutherland und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Vermont Larner College of Medicine, Burlington, Vermont, USA. Hauptthemen laut MEDLINE: Hallucinogens. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interest in psychedelic therapies for adults is rapidly growing, with substances like 3,4-methylenedioxymethamphetamine for posttraumatic stress disorder, psilocybin for treatment-resistant depression, and lysergic acid diethylamide for generalized anxiety disorder showing promise. However, research on these therapies in children and adolescents is limited, with no recent trials. Despite this lack of scientific exploration, adolescents may still experiment with these substances for both recreational and therapeutic purposes as accessibility continues to increase. This raises significant concerns, as adolescents are a vulnerable population requiring heightened caution and safety measures. Therefore, we advocate for structured, safe, and well-controlled exploration of psychedelic therapies in adolescents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensHumansAdolescentPsychopharmacologyPsilocybinStress Disorders, Post-TraumaticAnxiety DisordersLysergic Acid DiethylamideN-Methyl-3,4-methylenedioxyamphetamine

Stichwörter der Autor:innen

3,4-methylenedioxymethamphetamineadolescentlysergic acid diethylamidepsilocybinpsychedelic

Substanzen

HallucinogensPsilocybinLysergic Acid DiethylamideN-Methyl-3,4-methylenedioxyamphetamine

Autor:innen und Institutionen

  • University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Department of Molecular Pharmacology and Experimental Therapeutics, Rochester, MN, USA.

ORCID-Profile: Paul E Croarkin

Zitieren

APA

Sutherland, I., Ho, M. F., & Croarkin, P. E. (2025). Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2024.0082

Vancouver

Sutherland I, Ho MF, Croarkin PE. Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor. Journal of Child and Adolescent Psychopharmacology. 2025. doi:10.1089/cap.2024.0082

BibTeX
@article{Sutherland2025,
  author = {Sutherland, Isabella and Ho, Ming-Fen and Croarkin, Paul E},
  title = {Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2025},
  doi = {10.1089/cap.2024.0082}
}
Kostenlos starten →